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Abstract 
The use of radiation treatment (RT) is usually 
reserved for residual or recurrent craniopha-
ryngiomas, and the role of RT alone and not as 
an adjunctive therapy to surgery has not been 
clearly defined. The authors describe a case 
of a 50-year-old man presenting with a large 
suprasellar craniopharyngioma with exten-
sion into the third ventricle, producing acute 
hydrocephalus. A ventriculoperitoneal shunt 
was performed concurrently with an endoscopic 
biopsy. Treatment with fractionated stereotactic 
radiosurgery (FSR) resulted in near resolution of 
the lesion with no evidence of recurrence over 
six years. A review of RT for the treatment of 
craniopharyngiomas without surgical resection 
is performed.
Introduction
Craniopharyngiomas are histologically benign 
extraaxial epithelial tumors that arise form 
embryologic remnants of Rathke’s pouch.12 
These rare lesions have an estimated incidence 
of 1.5 per million people per year, but comprise 
10-15% of all pediatric brain tumors.7,21 Despite 
their benign histology, craniopharyngiomas 
cause significant morbidity from damage to the 
hypothalamus, optic apparatus, and endocrine 
system. Aggressive treatment is advocated, but 
the optimal treatment is often debated.
Radical resection is often utilized as a first line 
treatment due to the frequently large size of 
these lesions at presentation and associated 
mass effect.6,24 Such surgery, however, can carry 
a high risk of morbidity with hypothalamic and 
endocrine dysfunction.26 For this reason, many 
favor subtotal resection with preservation of 
adjacent anatomical structures and adjuvant 
therapies for residual tumor.11,18 The use of 
radiotherapy in isolation for the treatment of 
craniopharyngiomas is infrequent.
Case Report
A 50-year-old man suffering from two months 
of headache and neck pain presented to the 
emergency department with a dramatic deterio-
ration of his vision, limb paresis, and seizures. 
Cranial imaging demonstrated a 3.7 x 2.5 X 3.2 
cm, solid suprasellar mass with extension into 
the third ventricle, producing acute hydro-
cephalus (Figures 1 and 2). Through a right 
frontal burrhole, placement of a ventriculoperi-
toneal shunt was performed concurrently with 
an endoscopic biopsy of the third ventricular 
mass tumor (Figure 3). Intraoperatively, a 
yellow-colored frond-like mass with a consis-
tency similar to choroid plexus was seen filling 
the right foramen of Monro. Pathology was 
consistent with a papillary craniopharyngioma. 
The patient was subsequently treated with 
fractionated stereotactic radiosurgery (FSR) 
for a total of 54 Gy to the 88% isodose line in 
thirty 1.8 Gy fractions. Within a month of FSR 
completion, the tumor volume was reduced by 
nearly half and continued to diminish on each 
following imaging study. With six years of 
follow-up, the lesion continues to demonstrate 
near resolution with no recurrence and further 
treatment has not been necessary (Figure 4).
Discussion
The treatment of craniopharyngiomas is highly 
controversial. This controversy is further fueled 
by the myriad therapeutic modalities available: 
cystic drainage, intracavitary chemotherapy, 
limited resection or gross total resection (GTR), 
and radiation therapy. The greatest debate exists 
between those favoring radical surgical excision 
and those believing that subtotal resection fol-
lowed by adjuvant therapy is best to spare the 
potential morbidity associated with aggressive 
surgery. While criticisms of surgical treatment are 
largely based on the results of open approaches, 
the role of endoscopic endonasal resection in 
limiting that morbidity is unclear (Figure 5). 
Radiotherapy is most often used as an adjunc-
tive treatment for craniopharyngiomas, either 
in the setting of residual tumor after a subtotal 
resection or for tumor recurrence. Published 
series report a local control rate of 79-95% in 
these patients.2,13,14,18,19,22,23 In a review of their 
craniopharyngioma patients with long-term 
follow-up, Karavitaki et al. divided 121 patients 
into four groups: 1) GTR, 2) GTR plus RT, 3) 
sub-total resection (STR), and 4) STR plus RT. 
In this cohort, the ten year recurrence-free 
survival rates were 100%, 100%, 38%, and 77%, 
respectively.11 These results have been repro-
duced in the literature examining the newer 
techniques of fractionated radiation therapy. 
Typically, 45-55 Gy in 1.8-2.0 Gy fractions 
are utilized and ten year local control rates for 
surgery with postoperative FSR are 57-89% 
compared to 31-42% with surgery alone.25 
The effect of radiotherapy for craniopharyngio-
mas appears to be affected by the consistency of 
the lesion with more solid tumors having the 
highest average control rate of 90%. Tumors that 
are either cystic or mixed have rates of 88% and 
60%, respectively.25 The impact of histology on 
radiation effect is somewhat less clear. While 
some groups have not found a significant differ-
ence between adamantinomatous and papillary 
craniopharyngiomas, Inoue et al. did find a better 
response in the latter.4,10,15 
Most reports on radiotherapy discuss cranio-
pharyngioma stability and local tumor control. 
Few studies describe the effect on tumor size. 
Significant lesion reduction has been docu-
mented after fractionated external radiation3,8 
and stereotactic radiosurgery.27 In our reported 
patient, we observed significant tumor shrink-
age within one month and this effect has been 
sustained currently for six years, demonstrating 
FSR as a possible alternative for initial therapy in 
select cases. Despite this result, we continue to 
utilize and recommend surgery as the first line 
treatment for craniopharyngiomas. We reserve 
FSR for patients with a significant residual tumor 
residual or with recurrence. Despite its appeal as a 
Figure 1
Cranial CT upon initial presentation, demonstrating an isodense third ventricular mass with 
lateral ventricular dilatation
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Figure 2
(A) Coronal and (B) sagittal cranial T1WI MRI with gadolinium showing an enhancing supra-
sellar mass consistent with craniopharyngioma
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Figure 3
Cranial CT following ventriculoperitoneal 
shunt placement and endoscopic biopsy
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“less invasive” treatment, radiation is not a benign 
treatment. It can result in growth hormone deficit 
in pediatric patients, neurocognitive impairment, 
and optic neuropathy.9,17,20 Radiation effects 
to the hypothalamic-pituitary-adrenal axis may 
produce diabetes insipidus, panhypopituitarism, 
hypogonadism, hypothalamic obesity, and sleep 
disturbance.1,5,16
Conclusions
While surgery remains the initial treatment of 
choice for craniopharyngiomas, the debate 
between GTR versus STR and even open versus 
endoscopic endonasal approaches continues to 
persist. Radiotherapy is often reserved for resid-
ual or recurrent disease, but we have been able to 
show that, when necessary, FSR can be effective 
as an initial treatment. After establishment of a 
tissue diagnosis, solid papillary craniopharyngio-
mas may be the most suitable for radiotherapy if 
surgical resection is not feasible.
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Figure 5
Cranial T1WI MRI with gadolinium in a patient recently treated by the senior author (JJE) by 
an endoscopic endonasal approach; (A) and (B) preoperative sagittal and coronal images; (C) 
and (D) postoperative sagittal and coronal images following a complete resection 
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Figure 4
Sequential coronal and sagittal T1WI MRIs with gadolinium demonstrating progressive tumor 
regression at 1 month, 1 year, and 6 years after radiation
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